Table 3.
This table is an overview of the current recommendations for each type of treatment indicated in the literature [1,20]. Both generic names and brand names, when applicable, are provided. Adapted from “Clinical Features, Diagnosis, and Treatment of Erythema Multiforme: A Review for the Practicing Dermatologist” by Sokumbi et al. [1] with permission from John Wiley and Sons Publishing on behalf of the International Journal of Dermatology, © 2021.
| Medication Class | Generic Name | Brand Name |
|---|---|---|
| Antibiotic | Azithromycin | Zithromax |
| Dapsone | Aczone | |
| Anthelmintic | Levamisole | Ergamisol |
| Antimalarial | Hydroxychloroquine | Plaquenil |
| Antihistamine | Cimetidine | N/A |
| Antiviral | Acyclovir | Acyclovir, Zovirax |
| Famciclovir | Famvir | |
| Valacyclovir | Valaciclovir, Valtrex | |
| Immunosuppressant/immunomodulator | Adalimumab | Humira, Amjevita, and adalimumab-atto |
| Apremilast | Otezla | |
| Azathioprine | Imuran | |
| Cyclosporine | Ciclosporin, Gengraf, Neoral | |
| Immunoglobulin | Immune Globulin | |
| Mycophenolate mofetil | CellCept | |
| Thalidomide | Thalomid | |
| Steroids | Prednisone | N/A |